March 05, 2025
Article
Avoiding surgery for rectal cancer, Sarah Rack of Memphis traveled to Houston for treatment every three weeks for 18 months.
June 14, 2023
Patients with GIST have more treatment options than ever, with others currently under development.
December 20, 2022
HIF-2 alpha inhibitors are transforming therapy for patients with renal cell carcinoma and von Hippel-Lindau disease.
December 15, 2022
Podcast
When Sean Korbitz was a 20-year-old college student, his life trajectory changed with a rare cancer diagnosis, resulting in the removal of 40 tumors; fifteen years later, a new drug made him feel like a “medical miracle.”
The Benefit of Clinical Trial Enrollment for Patients With Cancer
Addressing Gaps, Challenges and Disparities in AYA Cancer Care
Unexpected Challenges 11 Years After Breast Cancer
Camrelizumab Combo Doubles 5-Year Survival in Phase 3 Lung Cancer Trial